Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heller, S. L.
Right arrow Articles by Brooke, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heller, S. L.
Right arrow Articles by Brooke, M. H.
NEUROLOGY 1987;37:1039
© 1987 American Academy of Neurology

McArdle's disease with myoadenylate deaminase deficiency

Observations in a combined enzyme deficiency

S. L. Heller, MD, K. K. Kaiser, BS, G. J. Planer, BS, J. M. Hagberg, PhD and M. H. Brooke, MD

Department of Neurology (Dr. Heller), Northwestern University Medical School, Chicago, IL; and the Department of Neurology (Mr. Kaiser, Mr. Planer, and Dr. Brooke) and Section of Applied Physiology, Department of Medicine (Dr. Hagberg), Washington University School of Medicine, St. Louis, MO.

Exercise and work potential of a patient with coexistent myophosphoryhse and myoadenylate deaminase (AMPDA) deficiency was compared with that of three patients with myophosphorylase deficiency alone. The patient with the combined defect failed to produce an abnormal rise in serum ammonia or hypoxanthine as seen in the other patients after forearm exercise. Maximum oxygen consumption and work rates during cycle egometer testing were similar in all patients, but well below controls. The occurrence of two defects involving short-term energy metabolism in muscle presents an opportunity to define further the metabolic role of AMPDA.

Address correspondence and reprint requests to Dr. Heller, Department of Neurology, Northwestern University Medical School, 301 E. Chicago Avenue, Chicago, IL 60611.

Supported by a grant from the Muscular Dystrophy Association.

Received June 17, 1986. Accepted for publication in final form October 7, 1986.




This article has been cited by other articles:


Home page
BrainHome page
J. Vissing, M. Duno, M. Schwartz, and R. G. Haller
Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease
Brain, June 1, 2009; 132(6): 1545 - 1552.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.